Literature DB >> 27889034

Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.

Chia-Ching J Wang1, Joseph Sparano2, Joel M Palefsky3.   

Abstract

Anal cancer is an increasingly common non-AIDS-defining cancer among individuals infected with the human immunodeficiency virus (HIV). It is associated with human papillomavirus (HPV). HPV16 is the most common genotype detected in anal cancers. The HPV types detected in anal cancer are included in the 9-valent vaccine. HPV vaccines have demonstrated efficacy in reducing anal precancerous lesions in HIV-infected individuals. Standard treatment has been fluorouracil and mitomycin (or cisplatin) plus radiation. Continued studies are needed to test new treatment strategies in HIV-infected patients with anal cancer to determine which treatment protocols provide the best therapeutic index. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anal cancer; HIV; HPV; HPV vaccination; Immunosuppression

Mesh：

Substances：

Year:  2017        PMID： 27889034      PMCID： PMC5331942          DOI： 10.1016/j.soc.2016.07.010

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  104 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

3.  Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.

Authors:  Eric A Engels; Ruth M Pfeiffer; Winnie Ricker; William Wheeler; Ruth Parsons; Joan L Warren
Journal:  Am J Epidemiol       Date:  2011-08-04       Impact factor: 4.897

4.  A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Authors:  Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

5.  Evaluation and Management of Anal Intraepithelial Neoplasia in HIV-Negative and HIV-Positive Men Who Have Sex with Men.

Authors:  Ina U Park; Joel M Palefsky
Journal:  Curr Infect Dis Rep       Date:  2010-02-24       Impact factor: 3.725

6.  The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.

Authors:  Anna R Giuliano; Eduardo Lazcano-Ponce; Luisa L Villa; Roberto Flores; Jorge Salmeron; Ji-Hyun Lee; Mary R Papenfuss; Martha Abrahamsen; Emily Jolles; Carrie M Nielson; Maria Luisa Baggio; Roberto Silva; Manuel Quiterio
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

7.  HIV and anal cancer outcomes: a single institution's experience.

Authors:  Melissa E Hogg; Daniel A Popowich; Ed C Wang; Kristina D Kiel; Steven J Stryker; Amy L Halverson
Journal:  Dis Colon Rectum       Date:  2009-05       Impact factor: 4.585

Review 8.  Clinical trials of human papillomavirus vaccines and beyond.

Authors:  Matti Lehtinen; Joakim Dillner
Journal:  Nat Rev Clin Oncol       Date:  2013-06-04       Impact factor: 66.675

9.  High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.

Authors:  Christophe Piketty; Teresa M Darragh; Isabelle Heard; Maria Da Costa; Patrick Bruneval; Michel D Kazatchkine; Joel M Palefsky
Journal:  Sex Transm Dis       Date:  2004-02       Impact factor: 2.830

Review 10.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316
View more
  17 in total

Review 1.  Pharmacotherapy of Anal Cancer.

Authors:  Jane E Rogers; Cathy Eng
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Topical application of a dual PI3K/mTOR inhibitor prevents anal carcinogenesis in a human papillomavirus mouse model of anal cancer.

Authors:  Brooks L Rademacher; Kristina A Matkowskyj; Emily D LaCount; Evie H Carchman
Journal:  Eur J Cancer Prev       Date:  2019-11       Impact factor: 2.497

3.  Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.

Authors:  Anna-Barbara Moscicki; Brad Karalius; Katherine Tassiopoulos; Tzy-Jyun Yao; Denise L Jacobson; Kunjal Patel; Murli Purswani; George R Seage
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

Review 4.  Anorectal pathology in the HIV population: a guide for radiologists.

Authors:  Derek Vos; Margaret Wang; Sita Ramaiya; Elias G Kikano; Sree H Tirumani; Daniel A Smith
Journal:  Abdom Radiol (NY)       Date:  2022-03-14

5.  The role of pharmacologic modulation of autophagy on anal cancer development in an HPV mouse model of carcinogenesis.

Authors:  Brooks L Rademacher; Kristina A Matkowskyj; Louise M Meske; Alexis Romero; Hana Sleiman; Evie H Carchman
Journal:  Virology       Date:  2017-04-18       Impact factor: 3.616

6.  A Cell-Based Renilla Luminescence Reporter Plasmid Assay for High-Throughput Screening to Identify Novel FDA-Approved Drug Inhibitors of HPV-16 Infection.

Authors:  Tara Walhart; Erin Isaacson-Wechsler; Kean-Hooi Ang; Michelle Arkin; Sharof Tugizov; Joel M Palefsky
Journal:  SLAS Discov       Date:  2019-07-30       Impact factor: 3.341

7.  Anal cancer survival: a socioeconomic analysis.

Authors:  F Ali; A E Ghareeb; A Jha; H Van der Voet; D Garg; M Jha
Journal:  Ann R Coll Surg Engl       Date:  2021-03       Impact factor: 1.951

Review 8.  Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.

Authors:  Nonkululeko N Mthembu; Zukile Mbita; Rodney Hull; Zodwa Dlamini
Journal:  HIV AIDS (Auckl)       Date:  2017-03-30

9.  Analysis of Nucleotide Alterations in the E6 Genomic Region of Human Papillomavirus Types 6 and 11 in Condyloma Acuminatum Samples from Brazil.

Authors:  Marina Carrara Dias; Bruna Stuqui; Paola Jocelan Scarin Provazzi; Cíntia Bittar; Natália Maria Candido; Renata Prandini Adum de Matos; Rodolfo Miglioli Badial; Caroline Measso do Bonfim; Patricia Pereira Dos Santos Melli; Silvana Maria Quintana; José Antônio Cordeiro; Paula Rahal; Marilia de Freitas Calmon
Journal:  Adv Virol       Date:  2019-05-02

Review 10.  Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy.

Authors:  Sigrun Smola
Journal:  Viruses       Date:  2017-09-12       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.